03869.HK
Hospital Corporation of China Limited
HKSE · Healthcare · Medical - Care Facilities · CN
HKD 3.40
+0.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.9B | 1.4B | 1.4B | 1.4B | 1.1B |
| Cost of Revenue | 2.4B | 1.2B | 1.2B | 1.2B | 992.1M |
| Gross Profit | 541.4M | 260.7M | 275.8M | 239.4M | 150.9M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 229.3M | 118.0M | 109.1M | 130.8M | 95.5M |
| General & Admin Expense | 171.3M | — | 109.0M | 129.2M | 95.2M |
| Selling & Marketing Expense | 178.0K | — | 161.0K | 1.6M | 344.0K |
| Other Expenses | (25.0M) | 38.1M | (15.2M) | (105.9M) | (5.9M) |
| Total Operating Expenses | 204.3M | 156.1M | 94.0M | 24.9M | 89.6M |
| Cost and Expenses | 2.6B | 1.3B | 1.3B | 1.2B | 1.7B |
| Operating Income (EBIT) | 337.1M | 104.6M | 181.9M | 214.5M | (538.0M) |
| Non-Operating | |||||
| Interest Income | 170.0M | 63.6M | 10.5M | 9.7M | 9.0M |
| Interest Expense | 123.1M | — | 2.6M | 2.5M | 4.9M |
| Net Interest Income | 46.9M | 63.6M | 7.9M | 7.3M | 4.1M |
| Other Non-Op Income/Expense | (89.0M) | 77.2M | (120.6M) | 88.4M | 5.4M |
| Non-Operating Income (excl Interest) | 2.2M | — | 1.6M | (6.1M) | (574.7M) |
| EBT (Pre-Tax Income) | 248.1M | 181.8M | 61.3M | 216.2M | (532.6M) |
| Income Tax Expense | 94.8M | 46.3M | 47.5M | 47.9M | (4.0M) |
| Bottom Line | |||||
| Net Income | 98.1M | 132.9M | (38.6M) | 131.4M | (480.9M) |
| Earnings from Cont. Ops | 153.3M | 135.4M | 13.8M | 168.3M | (528.6M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 98.1M | 69.2M | (38.6M) | 43.1M | (480.9M) |
| Per Share | |||||
| Basic EPS | HK$0.70 | HK$0.97 | (HK$0.28) | HK$0.96 | (HK$3.48) |
| Diluted EPS | (HK$0.17) | HK$0.34 | (HK$0.28) | HK$0.65 | (HK$3.48) |
| Revenue Per Share | HK$21.26 | HK$10.50 | HK$10.53 | HK$10.44 | HK$8.27 |
| Shares | |||||
| Basic Shares Outstanding | 136.5M | 136.5M | 137.0M | 136.7M | 138.2M |
| Diluted Shares Outstanding | 136.5M | 201.2M | 137.1M | 202.2M | 138.2M |
| Profitability Metrics | |||||
| EBITDA | 426.0M | 104.6M | 236.5M | 283.5M | (464.4M) |
| D&A | 91.0M | — | 56.2M | 62.9M | 63.3M |
| EBIT | 335.0M | 104.6M | 180.2M | 220.6M | (527.7M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025